블로그
- 모더나 - AACR 2026 암 학회 발표 주제 (4월 20일) First-Line mRNA-4359 plus pembrolizumab (pembro) in locally advanced or metastatic melanoma: Results from the phase 1/2 mRNA-4359-P101 study First-Line (1차 치료): 전에 이 병으로 항암치료를 받은 적이 없는 '신규 환자'를 뜻함 mRNA-
- 모더나 - AACR 2026 암 학회 발표 주제 (4월 20일) First-Line mRNA-4359 plus pembrolizumab (pembro) in locally advanced or metastatic melanoma: Results from the phase 1/2 mRNA-4359-P101 study First-Line (1차 치료): 전에 이 병으로 항암치료를 받은 적이 없는 '신규 환자'를 뜻함 mRNA-
- jun Tennis Scouting Report Ranking: Top 20 (Elementary Level, South Korea) UTR (Universal Tennis Rating): [If Available] Key Results Technical Evaluation Serve: Solid first serve with good placement; effectivel.......
- The AMAZING RESULTS of POSITIVE THINKING Positive thinking is a form of thought which habitually looks for the best results from the worse conditions (p.4) First, it is important to define what success means to you. Define your goal cle.......
- Phase III Trial Results Suggest a New Standard of Care in Metastatic HER2-Positive Breast Cancer Phase III Trial Results Suggest a New Standard of Care in Metastatic HER2-Positive Breast Cancer In the phase III DESTINY-Breast09 trial, first-line treatment with the antibody-drug conjugate fam-trastuzumab
- Bill Gates Predicts AI Future At first, it sounded like one of those billionaire fantasies. Some companies are already testing four-day work weeks with good results.
- 퍼스트솔라 (FSLR) Q4 2023 어닝콜 the Company issued a press release announcing its fourth quarter and the full-year 2023 financial results Alex will discuss our financial results for the fourth quarter and full-year 2023, as well as our fina
- ASML (ASML) Q1 2024 어닝콜 The subject of today's call is ASML's 2024 first quarter results.
- 파월 인더스트리 (POWL) Q1 2024 어닝콜 Thank you for joining us for Powell Industries conference call today to review fiscal year 2024 first quarter results.
- 서비스나우 (NOW) Q4 2023 어닝콜 During today's call, we will review our fourth quarter 2023 results and discuss our guidance for the first quarter and full year 2024.